|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61P 37/00 |
| (11) | Patento numeris | 3229827 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15885769.8 |
| Europos patento paraiškos padavimo data | 2015-12-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/079395 |
| Data | 2015-12-12 |
| (87) | Numeris | WO 2016/192819 |
| Data | 2016-12-08 |
| (30) | Numeris | Data | Šalis |
| 201462091379 P | 2014-12-12 | US |
| (72) |
MULLER, Sylviane, FR
ZIMMER, Robert H., FR
BRIAND, Jean-Paul, FR
|
| (73) |
ImmuPharma France SA,
5, rue du Rhōne, 68100 Mulhouse,
FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, 3, Rue Michel-Ange, 75794 Paris, FR |
| (54) | MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES |
| MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES |